Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;22(2):77-84.
doi: 10.1007/s11892-022-01448-1. Epub 2022 Feb 12.

Contraception for Adolescents and Young Women with Type 2 Diabetes-Specific Considerations

Paulina M Merino  1 , Ethel Codner  2
Affiliations
Review

Contraception for Adolescents and Young Women with Type 2 Diabetes-Specific Considerations

Paulina M Merino et al. Curr Diab Rep. 2022 Feb.

Abstract

Purpose of review: This article reviews how to address contraception in young women with type 2 diabetes (T2D). The presence of obesity and comorbidities associated with insulin resistance increases the risk of thromboembolic disease and adverse cardiovascular outcomes.

Recent findings: Recent studies have shown that adolescents with T2D are at high risk of unintended pregnancy with poor outcomes for the mother and offspring. Adolescents with T2D without severe obesity, micro- or macrovascular disease, or other cardiovascular risk factors can use any contraceptive method. However, only nonhormonal or progestin-only methods may be used when morbid obesity, severe hypertension, micro- or macrovascular disease, or multiple cardiovascular risk factors are present. The medical team must provide preconceptional counseling and contraception to reduce adolescent pregnancies in young women with T2D. Progestin-only or nonhormonal long-acting reversible contraception (LARC) should be recommended for women with T2D with compliance issues or adverse cardiovascular risk profiles.

Keywords: Adolescents; Contraception; Hormonal contraception; Long-acting reversible contraceptive; Obesity; Type 2 diabetes.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Koren D, Levitsky LL. Type 2 diabetes mellitus in childhood and adolescence. Pediatr Rev. 2021;42(4):167–79. https://doi.org/10.1542/pir.2019-0236 . - DOI - PubMed
    1. Kohn JR, Rajan SS, Kushner JA, Fox KA. Outcomes, care utilization, and expenditures in adolescent pregnancy complicated by diabetes. Pediatr Diabetes. 2019;20(6):769–77. https://doi.org/10.1111/pedi.12871 . - DOI - PubMed
    1. Klingensmith GJ, Pyle L, Nadeau KJ, Barbour LA, Goland RS, Willi SM, et al. Pregnancy outcomes in youth with type 2 diabetes: the TODAY study experience. Diabetes Care. 2016;39(1):122–9. https://doi.org/10.2337/dc15-1206 . - DOI - PubMed
    1. Barbour LA. Changing perspectives in pre-existing diabetes and obesity in pregnancy: maternal and infant short- and long-term outcomes. Curr Opin Endocrinol Diabetes Obes. 2014;21(4):257–63. https://doi.org/10.1097/MED.0000000000000079 . - DOI - PubMed
    1. Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, de Mouzon SH, et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr. 2009;90(5):1303–13. https://doi.org/10.3945/ajcn.2008.27416 . - DOI - PubMed - PMC

Publication types

LinkOut - more resources